Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lextro Bio Solutions is a Hyderabad-based CRO providing next-generation drug discovery technologies. Their offerings include recombinant protein production, antibody discovery (including fully human multi-specific mAbs), patient-derived organoid models for translational research, in vitro/in vivo pharmacology studies, lead identification/screening for novel biological/chemical/nucleic acid entities, mechanism-of-action studies with biomarker integration, and preclinical pharmacology/toxicology. They focus on accelerating client programs from concept to clinic across oncology/immunotherapy and other major therapeutic areas. No public data on internal clinical results or proprietary drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lextro Bio Solutions.